Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Transcriptomes of human mesenchymal cells isolated from the right ventricle and epicardial fat differ strikingly both directly after isolation and long-term culture.

Stępniewski J., Florczyk-Soluch U., Szade K., Bukowska-Strakova K., Czapla J., Matuszczak S.

Prospective Study on Cardiovascular Disease, published in ESC Heart Fail (2019) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
ESC Heart Fail (2019)
Country
England
Reported sample size
—
Source database
PubMed
PMID
30623613
PMCID
PMC6437551
DOI
10.1002/ehf2.12397
Citations
3

Abstract (original English)

Aims Mesenchymal stromal cells isolated from different tissues are claimed to demonstrate similar therapeutic potential and are often incorrectly named mesenchymal stem cells. However, through comparison of such cells is lacking. This study aimed to compare the transcriptome of mesenchymal cells of the same phenotype isolated from the heart muscle and epicardial fat of the same patient, before and after culture. Methods and results Cells were isolated from biopsies of the right ventricle and epicardial fat collected from five patients (three men and two women, mean age 59.4 ± 2.6) who underwent heart transplantation due to ischaemic cardiomyopathy. In both tissues, immunophenotyping revealed three distinct populations: (i)CD31 - CD45 - CD90 + CD34 + CD146 - , (ii) CD31 - CD45 - CD90 + CD34 - CD146 + , and (iii) CD31 - CD45 - CD90 - CD34 - CD146 + , of which only the first one could be grown after sorting. Material for RNA-seq was collected from these cells before culture (250 cells) and at passage 6 (5000 cells). Transcriptomic analysis revealed that cells of the same phenotype (CD31 - CD45 - CD90 + CD34 + CD146 - ) upon isolation preferentially clustered according to the tissue of origin, not to the patient from whom they were isolated. Genes up-regulated in the right ventricle-derived cells were related to muscle physiology while down-regulated genes included those encoding p

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueBiopsyCell DifferentiationCells, CulturedFemaleFlow CytometryGene Expression ProfilingHeart VentriclesHumansMale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research